Department of Rehabilitation Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Department of Physical Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Int J Environ Res Public Health. 2023 Jan 10;20(2):1285. doi: 10.3390/ijerph20021285.
The role of anxiety and depression in functional performance during walking in patients with chronic obstructive pulmonary disease (COPD) is controversial. In this cross-sectional study, we aimed to assess the effects of anxiety, depression, and health-related quality of life (HRQOL) on the functional performance of this patient population. Seventy COPD patients aged 63 ± 11 years participated in the study. To measure their functional performance, the six-minute walk test (6MWT) was used. Anxiety and depression were assessed using two questionnaires: the Anxiety Inventory for Respiratory Disease (AIR) scale and the Hospital Anxiety and Depression Scale (HADS). The St. George’s Respiratory Questionnaire (SGRQ) was used to assess HRQOL. Based on their anxiety levels, the patients were divided into a no anxiety group and a high anxiety group. There were no significant differences between the two groups in terms of pulmonary function profile or smoking status. The mean AIR and HADS (depression) scores were high (12.78 ± 4.07 and 9.90 ± 3.41, respectively). More than one-third of the patients (46%) reported high anxiety levels (above the standard cutoff score of 8). The mean score of the aggregated HADS scale was significantly higher in the high anxiety group (20.87 ± 6.13) than in the no anxiety group (9.26 ± 4.72; p = 0.01). Patients with high anxiety had poorer functional performance (6MWT: 308.75 ± 120.16 m) and HRQOL (SGRQ: 56.54 ± 22.36) than patients with no anxiety (6MWT: 373.76 ± 106.56 m; SGRQ: 42.90 ± 24.76; p < 0.01). The final multivariate model explained 33% of the variance in functional performance after controlling for COPD severity (F = 8.97). The results suggest that anxiety, depression, and poor health status are significantly associated with poor functional performance. This study highlights the need to screen patients with COPD at all stages for anxiety and depression.
焦虑和抑郁在慢性阻塞性肺疾病(COPD)患者行走功能中的作用存在争议。在这项横断面研究中,我们旨在评估焦虑、抑郁和健康相关生活质量(HRQOL)对该患者群体功能表现的影响。70 名年龄为 63±11 岁的 COPD 患者参与了研究。为了测量他们的功能表现,使用了 6 分钟步行测试(6MWT)。使用两种问卷评估焦虑和抑郁:呼吸疾病焦虑量表(AIR)和医院焦虑抑郁量表(HADS)。圣乔治呼吸问卷(SGRQ)用于评估 HRQOL。根据他们的焦虑水平,患者分为无焦虑组和高焦虑组。两组在肺功能特征或吸烟状况方面无显著差异。平均 AIR 和 HADS(抑郁)评分较高(分别为 12.78±4.07 和 9.90±3.41)。超过三分之一的患者(46%)报告存在高焦虑水平(高于 8 的标准临界值)。高焦虑组的综合 HADS 评分平均值明显高于无焦虑组(20.87±6.13 比 9.26±4.72;p=0.01)。高焦虑组患者的功能表现(6MWT:308.75±120.16m)和 HRQOL(SGRQ:56.54±22.36)较差,而无焦虑组患者的功能表现(6MWT:373.76±106.56m;SGRQ:42.90±24.76;p<0.01)。在控制 COPD 严重程度后,最终的多元模型解释了功能表现 33%的方差(F=8.97)。结果表明,焦虑、抑郁和健康状况不佳与功能表现不佳显著相关。这项研究强调了需要在 COPD 的所有阶段对患者进行焦虑和抑郁筛查。